|
PF-54940 |
FLIXOTIDE NEBULES 0.5 mg/2 mL Suspensión para inhalación |
2023-02-08 |
|
Glaxosmithkline Australia Pty Ltd |
Australia
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39521 |
RELENZA 5 mg Polvo para inhalación |
2012-09-27 |
|
Glaxosmithkline PLC |
Australia
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-52619 |
FLUARIX TETRA Suspensión inyectable |
2026-03-22 |
|
GlaxoSmithKline Biologicals, Alemania |
Alemania
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-54730 |
ENGERIX B Dosis Pediátrica 10 mcg/0.5 mL Suspensión inyectable |
2022-12-06 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-55010 |
TWINRIX Suspensión inyectable |
2023-03-09 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-35399 |
ROTARIX Liofilizado para Suspension Oral |
2010-05-20 |
|
Glaxosmithkline Mexico, S.A De C.V. |
Bélgica
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-22028 |
INFANRIX IPV+HIB Polvo y suspensión para suspensión inyectable |
2024-11-19 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala S.A. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-39921 |
INFANRIX DTPa Suspensión Inyectable |
2017-12-06 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-40093 |
INFANRIX HEXA Polvo y suspensión para suspensión inyectable |
2028-03-23 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PF-41025 |
MENCEVAX ACWY Polvo liofilizado y solución para uso parenteral |
2018-07-31 |
|
GlaxoSmithkline Biologicals, S.A. |
Bélgica
|
Glaxosmithkline Guatemala |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|